Results 131 to 140 of about 95,531 (236)

Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs [PDF]

open access: yes, 2009
Treatment with praziquantel (PZQ) has become virtually the sole basis of schistosomiasis control in sub-Saharan Africa and elsewhere, and the drug is reviewed here in the context of the increasing rate that it is being used for this purpose. Attention is
A. MBAYE   +22 more
core   +2 more sources

Changing Patterns of Spatial Clustering of Schistosomiasis in Southwest China between 1999–2001 and 2007–2008: Assessing Progress toward Eradication after the World Bank Loan Project [PDF]

open access: yes, 2014
We compared changes in the spatial clustering of schistosomiasis in Southwest China at the conclusion of and six years following the end of the World Bank Loan Project (WBLP), the control strategy of which was focused on the large-scale use of ...
Cohen, Ted   +7 more
core   +2 more sources

Epidemiological features and control of schistosomiasis japonica in China [PDF]

open access: yesMemórias do Instituto Oswaldo Cruz, 1992
Achievements and successes have been obtained in schistosomiasis control in China. An epidemic survey was carried out and its results analyzed.
openaire   +5 more sources

Five-year impact of repeated praziquantel treatment on subclinical morbidity due to Schistosoma japonicum in China [PDF]

open access: yes, 2017
We report the 5-year impact (1996-2001) of repeated praziquantel chemotherapy on subclinical morbidity related to Schistosoma japonicum infection. We repeated stool examinations and hepatosplenic ultrasonography in a cohort of 120 individuals living on ...
Dessein, A.   +6 more
core  

Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: re-infection, subclinical disease and fibrosis marker measurements [PDF]

open access: yes, 2017
We studied a community cohort of 193 individuals exposed to endemic Schistosoma japonicum infection in the Dongting Lake region of China to assess subclinical morbidity and the 2-year benefit of curative therapy (praziquantel) administered in 1996 ...
Li, Y.   +6 more
core  

Direct amplification and differentiation of pathogenic and nonpathogenic Entamoeba histolytica DNA from stool specimens [PDF]

open access: yes, 1994
Discrimination of pathogenic and nonpathogenic Entamoeba histolytica is of great clinical importance. A simple and rapid DNA extraction method that can be used directly with stool specimens was developed without the need for prior cultivation of the ...
Katzwinkel-Wladarsch, S.   +2 more
core   +1 more source

The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer) [PDF]

open access: yes, 2017
Praziquantel has been the mainstay of schistosomiasis control since 1984 and widely distributed since 2006 through ‘preventive chemotherapy' programmes to school-aged children or at-risk populations.
Delgado-Romero, Petra   +2 more
core  

Effects of Polymorphisms in the SjSP-13 Gene of Schistosoma japonicum on Its Diagnostic Efficacy and Immunogenicity

open access: yesFrontiers in Microbiology, 2018
Schistosomiasis japonica is one of the most prevalent parasitic diseases in China. The scarcity of effective diagnostic tools is a major factor that contributes to the high prevalence of schistosomiasis japonica.
Xindong Xu   +7 more
doaj   +1 more source

Patent Landscape of Helminth Vaccines and Related Technologies [PDF]

open access: yes, 2013
Executive Summary This report focuses on patent landscape analysis of technologies related to vaccines targeting parasitic worms, also known as helminths.
Burke, Rayna   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy